{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:18:22Z","timestamp":1784888302608,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011057","name":"National Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejmech.2026.118863","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:10:06Z","timestamp":1776575406000},"page":"118863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Repurpose antimalarials to target Toxoplasma gondii dihydrofolate reductase thymidylate synthase"],"prefix":"10.1016","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5303-9580","authenticated-orcid":false,"given":"Sasithorn","family":"Decharuangsilp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuanchai","family":"Koompapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uthai","family":"Arwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nongnaput","family":"Tuyapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hoarau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokachet","family":"Tanasugarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutharat","family":"Pengon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwadee","family":"Talawanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanaya","family":"Saeyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarunee","family":"Vanichtanankul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyuth","family":"Yuthavong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumalee","family":"Kamchonwongpaisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-4213","authenticated-orcid":false,"given":"Aongart","family":"Mahittikorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin","family":"Kongkasuriyachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118863_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1586\/eri.12.58","article-title":"Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment","volume":"10","author":"Moncada","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2026.118863_bib2","first-page":"1368","article-title":"Anti-toxoplasmosis drugs","volume":"2","author":"Derouin","year":"2001","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2026.118863_bib3","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug resistance in Toxoplasma gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118863_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.118863_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111711","article-title":"Recent progress on anti-Toxoplasma drugs discovery: design, synthesis and screening","volume":"183","author":"Deng","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118863_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/AAC.45.4.1271-1277.2001","article-title":"In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase","volume":"45","author":"Reynolds","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118863_bib7","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1073\/pnas.90.24.11703","article-title":"Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria","volume":"90","author":"Donald","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118863_bib8","doi-asserted-by":"crossref","first-page":"16823","DOI":"10.1073\/pnas.1204556109","article-title":"Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target","volume":"109","author":"Yuthavong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118863_bib9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acschembio.1c00627","article-title":"Structural Insight into effective inhibitors' binding to Toxoplasma gondii dihydrofolate reductase thymidylate synthase","volume":"17","author":"Vanichtanankul","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118863_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107789","article-title":"Flexible 2,4-diaminopyrimidine bearing a butyrolactone as Plasmodium falciparum dihydrofolate reductase inhibitors","volume":"153","author":"Decharuangsilp","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118863_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/ac0487597","article-title":"Stoichiometric selection of tight-binding inhibitors by wild-type and mutant forms of malarial (Plasmodium falciparum) dihydrofolate reductase","volume":"77","author":"Kamchonwongpaisan","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.118863_bib12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1021\/acs.jmedchem.8b01754","article-title":"Discovery of selective Toxoplasma gondii dihydrofolate reductase inhibitors for the treatment of toxoplasmosis","volume":"62","author":"Hopper","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118863_bib13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1189\/jlb.0403164","article-title":"A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis","volume":"74","author":"Mordue","year":"2003","journal-title":"J. Leucocyte Biol."},{"key":"10.1016\/j.ejmech.2026.118863_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijpara.2006.01.006","article-title":"Proliferation of Toxoplasma gondii in inflammatory macrophages in vivo is associated with diminished oxygen radical production in the host cell","volume":"36","author":"Shrestha","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2026.118863_bib15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2026.118863_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000190","article-title":"Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo","volume":"2","author":"Mui","year":"2008","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.118863_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exppara.2019.05.001","article-title":"Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil","volume":"202","author":"Silva","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2026.118863_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13071-020-04094-2","article-title":"Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain","volume":"13","author":"Liu","year":"2020","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2026.118863_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004790","article-title":"Performance testing of PCR assay in blood samples for the diagnosis of toxoplasmic encephalitis in AIDS patients from the French departments of America and genetic diversity of Toxoplasma gondii: a prospective and multicentric study","volume":"10","author":"Ajzenberg","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.118863_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2026.118863_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta. Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.118863_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta. Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118863_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta. Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118863_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: more and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.118863_bib25","author":"Schr\u00f6dinger"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:18:44Z","timestamp":1781792324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0223523426003089"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118863","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurpose antimalarials to target Toxoplasma gondii dihydrofolate reductase thymidylate synthase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118863"}}